Effect of PH and Iron Concentration on Growth of Candida Albicans in Human Serum
Overview
Affiliations
Miao J, Willems H, Peters B Infect Immun. 2020; 89(2).
PMID: 33106292 PMC: 7822140. DOI: 10.1128/IAI.00550-20.
Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans.
Kim K, Zilbermintz L, Martchenko M Ann Clin Microbiol Antimicrob. 2015; 14:32.
PMID: 26054754 PMC: 4462072. DOI: 10.1186/s12941-015-0090-4.
Bai C, Chan F, Wang Y Biochem J. 2005; 389(Pt 1):27-35.
PMID: 15725072 PMC: 1184536. DOI: 10.1042/BJ20050223.
Cell wall and secreted proteins of Candida albicans: identification, function, and expression.
Chaffin W, Lopez-Ribot J, Casanova M, Gozalbo D, Martinez J Microbiol Mol Biol Rev. 1998; 62(1):130-80.
PMID: 9529890 PMC: 98909. DOI: 10.1128/MMBR.62.1.130-180.1998.
Production of a hemolytic factor by Candida albicans.
Manns J, Mosser D, Buckley H Infect Immun. 1994; 62(11):5154-6.
PMID: 7927798 PMC: 303238. DOI: 10.1128/iai.62.11.5154-5156.1994.